Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 4626 - 4650 of 5934 in total
Investigational
Investigational
Investigational
Experimental
Matched Iupac: … [azaniumyl({2-[(6-carbamimidoyl-1H-1,3-benzodiazol-2-yl)dihydroxymethyl]-1H-1,3-benzodiazol-6-yl})methylidene …
Lanraplenib is under investigation in clinical trial NCT03285711 (Safety and Efficacy of Filgotinib and Lanraplenib in Adults With Lupus Membranous Nephropathy (LMN)).
Investigational
Matched Iupac: … 6-[8-({4-[4-(oxetan-3-yl)piperazin-1-yl]phenyl}amino)imidazo[1,2-a]pyrazin-6-yl]pyrazin-2-amine …
Nanatinostat is under investigation in clinical trial NCT00697879 (Safety Study of the Histone Deacetylase Inhibitor, CHR-3996, in Patients With Advanced Solid Tumours).
Investigational
Matched Iupac: … 2-[(1R,5S,6R)-6-{[(6-fluoroquinolin-2-yl)methyl]amino}-3-azabicyclo[3.1.0]hexan-3-yl]-N-hydroxypyrimidine …
Experimental
Matched Iupac: … {[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-2-({[hydroxy({hydroxy[(3R)-3-hydroxy-3-[(2-{[2-(4 …
Gabexate is a synthetic serine protease inhibitor which has been used as an anticoagulant. It also known to decrease production of inflammatory cytokines. Gabexate has been investigated for use in cancer, ischemia-reperfusion injury, and pancreatitis.[A19218,A19219,A19220]
Investigational
Matched Iupac: … ethyl 4-[(6-carbamimidamidohexanoyl)oxy]benzoate …
Investigational
TRO40303 is under investigation in clinical trial NCT01374321 (Safety and Efficacy Study of TRO40303 for Reduction of Reperfusion Injury in Patients Undergoing Percutaneous Coronary Intervention for Acute Myocardial Infarction).
Investigational
Matched Iupac: … 3-[(3R,3aR,5aS,6R,7E,9aS,9bS)-7-(hydroxyimino)-3a,6-dimethyl-3-[(2R)-6-methylheptan-2-yl]-dodecahydro ... -1H-cyclopenta[a]naphthalen-6-yl]propan-1-ol …
Cinpanemab is under investigation in clinical trial NCT03318523 (Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Participants With Parkinson's Disease).
Investigational
Cyclotheonamide A is a cyclic peptide isolated from the marine sponge Theonella.
Experimental
Matched Iupac: … N-[(3S,7R,10S,16S,21aS)-7-benzyl-3-(3-carbamimidamidopropyl)-10-[(4-hydroxyphenyl)methyl]-1,4,5,8,13,17 …
Experimental
Matched Iupac: … (2R,3S,4R,5R,6S)-2-(hydroxymethyl)-6-(6-methyl-1H-1,3-benzodiazol-2-yl)oxane-3,4,5-triol …
Experimental
Matched Iupac: … 2-butanoyl-6-[(3-butanoyl-2,4-dihydroxy-6-methoxyphenyl)methyl]-3,5-dihydroxy-4,4-dimethylcyclohexa-2,5 …
Experimental
Matched Iupac: … 6-amino-1,2,3,4-tetrahydrophthalazine-1,4-dione …
Experimental
Matched Iupac: … 6-amino-2-methylheptan-2-ol …
Experimental
Matched Iupac: … 6-[2-(4-hydroxy-3-nitrophenyl)acetamido]hexanoate …
Vet approved
Matched Iupac: … 4-amino-6-(1,2,2-trichloroethenyl)benzene-1,3-disulfonamide …
Experimental
Matched Iupac: … 6-methyl-2-sulfanylidene-1,2,3,4-tetrahydropyrimidin-4-one …
Experimental
Matched Iupac: … 6-benzyl-2-sulfanylidene-1,2,3,4-tetrahydropyrimidin-4-one …
Experimental
Matched Iupac: … hexadecyltrimethylazanium (2S)-2-(6-methoxynaphthalen-2-yl)propanoate …
PXT 3003 is in phase 3 clinical trials for the treatment of Charcot-Marie-Tooth disease type 1A in adults.
Investigational
Matched Iupac: … ethyl 5-(benzylamino)-6-(cyclohexylamino)pyridine-3-carboxylate …
Experimental
Matched Iupac: … 2-fluoro-6-(3-hydroxybenzoyloxy)phenyl 3-hydroxybenzoate …
Displaying drugs 4626 - 4650 of 5934 in total